Yong-Ku Kim
Springer Nature Singapore
e druk, 2018
9789811043574
Treatment Resistance in Psychiatry
Risk Factors, Biology, and Management
Specificaties
Gebonden, blz.
|
Engels
Springer Nature Singapore |
e druk, 2018
ISBN13: 9789811043574
Rubricering
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This book reviews all the important aspects of treatment-resistant psychiatric disorders, covering issues such as definitions, clinical aspects, neurobiological correlates, treatment options, and predictors of treatment response. The book is divided into three sections, the first of which examines the most recent thinking on treatment resistance in psychiatry, including definition and epidemiology, paradigm shift in the study of the subjects, individual susceptibility and resilience, abnormal structural or functional connectivity, and insights from animal models. The second section then discusses treatment resistance in each of the major psychiatric disorders, with particular focus on the responsible clinical and biological factors and the available management strategies. Finally, more detailed information is presented on diverse pharmacological and non-pharmacological therapeutic interventions. The book, written by leading experts from across the world, will be of value to all who seek a better understanding of the clinical-neurobiological underpinnings and the development of management for treatment resistance in psychiatric disorders.
Specificaties
ISBN13:9789811043574
Taal:Engels
Bindwijze:gebonden
Uitgever:Springer Nature Singapore
Inhoudsopgave
<p><br></p>
<p>Part I. Rethinking the treatment resistance in psychiatry</p>
<p> </p>
<p>Chapter 1. Definition and epidemiology of treatment resistance in psychiatry</p>
<p>Sanne Smith-Apeldoorn, Jolien Veraart, Robert Schoevers </p>
Department of Psychiatry, University Medical Center Groningen, University of Groningen, the Netherlands<p></p>
<p> </p>
<p>Chapter 2. Paradigm shift in study of treatment resistant psychiatric disorder</p>
<p>Sang-Won Jeon <sup>1</sup> Meysam Amidfar,<sup>2</sup> Yong-Ku Kim<sup>3</sup></p>
<p><sup>1</sup> Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea</p>
<p><sup>2 </sup>Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</p>
<p><sup>3</sup> Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea</p>
<p> </p>
<p>Chapter 3. Genetic factors underlying treatment resistance in psychiatry</p>
<p>Eduard Maron, Chenchia Lan, David Nutt </p>
<p>Faculty of Medicine, Department of Medicine, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK </p>
<p> </p>
<p>Chapter 4. Using neuroimaging and electroencephalography for</p>
<p>prediction of treatment resistance in psychiatric disorders </p>
<p> </p>
<p>Je_Yeon Yun, <sup>1</sup>Seung-Hwan Lee<sup>2 </sup></p>
<p><sup>1</sup>Seoul National University Hospital, Seoul, Republic of Korea</p>
<p><sup>2</sup> Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, </p>
<p>Republic of Korea. </p>
<p> </p>
<p>Chapter 5. Developing therapies for treatment-resistant depressive disorders in animal models</p>
<p>Michel Bourin<br> Neurobiology of anxiety and mood disorders, University of Nantes, France</p>
<p> </p>
<p>Chapter 6. Integrated approaches to treatment-resistant psychiatric disorders</p>
<p>Seon-Cheol Park,<sup>1</sup> Yong-Ku Kim<sup>2</sup></p>
<p><sup>1</sup> Department of Psychiatry, Inje University College of Medicine and Haeundae Paik Hospital, Busan, Republic of Korea</p>
<p><sup>2 </sup>Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea</p>
<p> </p>
<p> </p>
<p>Part II. Treatment resistance in specific disorders</p>
<p> </p>
<p>Chapter 7. Treatment resistant depression: understandings on the neurobiological etiology that lead to novel pharmacological treatment options</p>
<p>Eunsoo Won, Byoung-Joo Ham, Yong-Ku Kim,</p>
<p>Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea</p>
<p> </p>
<p>Chapter 8. Treatment Resistant Schizophrenia: assessment and management</p>
Sandeep Grover, Harsh Garekar, Anisha Agarwal<br> Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India <p></p>
<p> </p>
<p>Chapter 9. Treatment resistance in bipolar disorders</p>
<p>Marsal Sanches, Joao Quevedo, Jair C, Soares</p>
<p>Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.</p>
<p> </p>
<p>Chapter 10. Treatment resistance in post-traumatic stress disorder </p>
Alexander Cowell McFarlane,<p></p>
<p>The Centre for Traumatic Stress Studies, The University of Adelaide, Adelaide, Australia<br> <br> </p>
<p>Chapter 11. Treatment resistance in obsessive compulsive disorder</p>
<p>Rachel Middleton, Michael G. Wheaton, Reilly Kayser, H. Blair Simpson</p>
<p>New York State Psychiatric Institute/Columbia Psychiatry, Columbia University Medical Center, New York, USA </p>
<p> </p>
<p>Chapter 12. Treatment of opioid dependence</p>
<p>Michael Soyka,</p>
<p>Psychiatric Hospital, University of Munich, Munich, Germany</p>
<p> </p>
<p>Chapter 13. Treatment-resistant panic disorder</p>
<p>Mu-Hong Chen, Shih-Jen Tsai,</p>
<p>Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan</p>
<p> </p>
<p>Chapter 14. Treatment resistance in anxiety disorder: generalized anxiety disorder, social anxiety disorder</p>
Kang Soo Lee, Sang Huk Lee<p></p>
<p>Department of Psychiatry, School of Medicine, CHA University, CHA Bundang Medical Center, Seongnam, Korea</p>
<p> </p>
<p>Chapter 15. Treatment resistance in Attention-Deficit Hyperactivity Disorder</p>
<p>Amber D. Hunt, David W. Dunn, Hillary S. Blake, Jen Downs </p>
Department of Psychiatry and Neurology, Riley Hospital Child and Adolescent Psychiatry Clinics, Indiana University School of Medicine, Indianapolis, USA.<p></p>
<p> </p>
<p>Chapter 16. Treatment resistance in Tourette syndrome</p>
<p>Renata Rizzo,<sup>1 </sup>Mariangela Gulisano<sup>2</sup><br> <sup>1</sup>Child and Adolescent Neurology and Psychiatry, School of Medicine, University of Catania, Catania, Italy</p>
<p><sup>2</sup> Child and Adolescent Neurology and Psychiatry Clinics, Policlinico, Catania, Italy</p>
<p> </p>
<p>Chapter 17. Treatment-Resistance Eating Disorders</p>
<p>Youl-Ri Kim,, Jione Kim</p>
Department of Psychiatry, Seoul Paik Hospital, Institute of Eating Disorders and Mental Health, Inje University, Seoul Paik Hospital, Inje University, Republic of Korea<p></p>
<p> </p>
<p>Chapter 18. Comorbid sleep and wake problems in treatment-resistant psychiatric conditions</p>
<p> </p>
<p>Seung Gul Kang,<sup>1 </sup>Heon-Jeong Lee,<sup>2</sup> Yong-Ku Kim,<sup>2</sup> Leen Kim<sup>2</sup> </p>
<p><sup>1</sup>Department of Psychiatry, Gil Medical Center, Gachon University, College of Medicine, Incheon, Republic of Korea</p>
<p><sup>2</sup>Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea</p>
<p> </p>
<p>Part III. Therapeutic intervention for treatment resistance</p>
<p> </p>
<p>Chapter 19. Creative, person-centered psychopharmacology for treatment resistance in psychiatry</p>
<p>Miro Jakovljevic</p>
<p>University Hospital Centre Zagreb, Department of Psychiatry, Zagreb, Croatia</p>
<p> </p>
<p>Chapter 20. A psychodynamic approach to treatment resistance</p>
<p>Elizabeth Weinberg, Erin Seery, Eric M. Plakun, </p>
<p>The Austen Rigges Center, Stockbridge, MA, USA </p>
<p> </p>
<p>Chapter 21. Cognitive behavioral therapy and behavioral activation therapy for treatment resistant depression: traditional and digital therapy perspectives</p>
Jennifer A. Apolinário-Hagen, Lara Fritsche, Liesemarie Albers, Christel Salewski <p></p>
<p>Department of Health Psychology, University of Hagen, Hagen, Germany. </p>
<p> </p>
<p>Chapter 22. Novel neurostimulation therapeutic approaches for treatment resistant psychiatric disorders</p>
<p>Ralph J. Koek, Janine Roach, Nicholas Athanasiou, Arkady Korotinsky</p>
<p>Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the UCLA, Los Angeles, USA</p>
<p> </p>
<p>Chapter 23. When clozapine fails: augmentation strategies in the management of clozapine-resistant schizophrenia</p>
<p> </p>
<p>Domenico De Berardis,<sup>1</sup> Michele Fornaro, Annalisa Anastasia, Federica Vellante , Alessandro Valchera, Marilde Cavuto, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Laura Orsolini, Carmine Tomasetti, Gabriella Di Emidio, Giovanni Martinotti, Massimo Di Giannantonio </p>
<p><sup>1</sup>NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy</p>
<p> </p>
<p>Chapter 24. Fecal microbiota transplantation in the treatment resistant psychiatric disorders</p>
<p>Alper Evrensel, Mehmet Emin Ceylan </p>
<p>Department of Psychiatry, Uskudar University, Istanbul, Turkey</p>
<p> </p>
<p>Chapter 25. Neurosurgical intervention for treatment-resistant psychiatric disorders</p>
<p>Daniel E. Nijensohn,<sup>1</sup> Teodoro Forcht Dagi <sup>2</sup></p>
<p><sup>1</sup> Honorary Professor, Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA </p>
<p><sup>2 </sup>Distinguished Scholar and Professor at the School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, Northern Ireland</p>
<p> </p><p></p>
<p>Part I. Rethinking the treatment resistance in psychiatry</p>
<p> </p>
<p>Chapter 1. Definition and epidemiology of treatment resistance in psychiatry</p>
<p>Sanne Smith-Apeldoorn, Jolien Veraart, Robert Schoevers </p>
Department of Psychiatry, University Medical Center Groningen, University of Groningen, the Netherlands<p></p>
<p> </p>
<p>Chapter 2. Paradigm shift in study of treatment resistant psychiatric disorder</p>
<p>Sang-Won Jeon <sup>1</sup> Meysam Amidfar,<sup>2</sup> Yong-Ku Kim<sup>3</sup></p>
<p><sup>1</sup> Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea</p>
<p><sup>2 </sup>Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</p>
<p><sup>3</sup> Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea</p>
<p> </p>
<p>Chapter 3. Genetic factors underlying treatment resistance in psychiatry</p>
<p>Eduard Maron, Chenchia Lan, David Nutt </p>
<p>Faculty of Medicine, Department of Medicine, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK </p>
<p> </p>
<p>Chapter 4. Using neuroimaging and electroencephalography for</p>
<p>prediction of treatment resistance in psychiatric disorders </p>
<p> </p>
<p>Je_Yeon Yun, <sup>1</sup>Seung-Hwan Lee<sup>2 </sup></p>
<p><sup>1</sup>Seoul National University Hospital, Seoul, Republic of Korea</p>
<p><sup>2</sup> Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, </p>
<p>Republic of Korea. </p>
<p> </p>
<p>Chapter 5. Developing therapies for treatment-resistant depressive disorders in animal models</p>
<p>Michel Bourin<br> Neurobiology of anxiety and mood disorders, University of Nantes, France</p>
<p> </p>
<p>Chapter 6. Integrated approaches to treatment-resistant psychiatric disorders</p>
<p>Seon-Cheol Park,<sup>1</sup> Yong-Ku Kim<sup>2</sup></p>
<p><sup>1</sup> Department of Psychiatry, Inje University College of Medicine and Haeundae Paik Hospital, Busan, Republic of Korea</p>
<p><sup>2 </sup>Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea</p>
<p> </p>
<p> </p>
<p>Part II. Treatment resistance in specific disorders</p>
<p> </p>
<p>Chapter 7. Treatment resistant depression: understandings on the neurobiological etiology that lead to novel pharmacological treatment options</p>
<p>Eunsoo Won, Byoung-Joo Ham, Yong-Ku Kim,</p>
<p>Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea</p>
<p> </p>
<p>Chapter 8. Treatment Resistant Schizophrenia: assessment and management</p>
Sandeep Grover, Harsh Garekar, Anisha Agarwal<br> Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India <p></p>
<p> </p>
<p>Chapter 9. Treatment resistance in bipolar disorders</p>
<p>Marsal Sanches, Joao Quevedo, Jair C, Soares</p>
<p>Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.</p>
<p> </p>
<p>Chapter 10. Treatment resistance in post-traumatic stress disorder </p>
Alexander Cowell McFarlane,<p></p>
<p>The Centre for Traumatic Stress Studies, The University of Adelaide, Adelaide, Australia<br> <br> </p>
<p>Chapter 11. Treatment resistance in obsessive compulsive disorder</p>
<p>Rachel Middleton, Michael G. Wheaton, Reilly Kayser, H. Blair Simpson</p>
<p>New York State Psychiatric Institute/Columbia Psychiatry, Columbia University Medical Center, New York, USA </p>
<p> </p>
<p>Chapter 12. Treatment of opioid dependence</p>
<p>Michael Soyka,</p>
<p>Psychiatric Hospital, University of Munich, Munich, Germany</p>
<p> </p>
<p>Chapter 13. Treatment-resistant panic disorder</p>
<p>Mu-Hong Chen, Shih-Jen Tsai,</p>
<p>Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan</p>
<p> </p>
<p>Chapter 14. Treatment resistance in anxiety disorder: generalized anxiety disorder, social anxiety disorder</p>
Kang Soo Lee, Sang Huk Lee<p></p>
<p>Department of Psychiatry, School of Medicine, CHA University, CHA Bundang Medical Center, Seongnam, Korea</p>
<p> </p>
<p>Chapter 15. Treatment resistance in Attention-Deficit Hyperactivity Disorder</p>
<p>Amber D. Hunt, David W. Dunn, Hillary S. Blake, Jen Downs </p>
Department of Psychiatry and Neurology, Riley Hospital Child and Adolescent Psychiatry Clinics, Indiana University School of Medicine, Indianapolis, USA.<p></p>
<p> </p>
<p>Chapter 16. Treatment resistance in Tourette syndrome</p>
<p>Renata Rizzo,<sup>1 </sup>Mariangela Gulisano<sup>2</sup><br> <sup>1</sup>Child and Adolescent Neurology and Psychiatry, School of Medicine, University of Catania, Catania, Italy</p>
<p><sup>2</sup> Child and Adolescent Neurology and Psychiatry Clinics, Policlinico, Catania, Italy</p>
<p> </p>
<p>Chapter 17. Treatment-Resistance Eating Disorders</p>
<p>Youl-Ri Kim,, Jione Kim</p>
Department of Psychiatry, Seoul Paik Hospital, Institute of Eating Disorders and Mental Health, Inje University, Seoul Paik Hospital, Inje University, Republic of Korea<p></p>
<p> </p>
<p>Chapter 18. Comorbid sleep and wake problems in treatment-resistant psychiatric conditions</p>
<p> </p>
<p>Seung Gul Kang,<sup>1 </sup>Heon-Jeong Lee,<sup>2</sup> Yong-Ku Kim,<sup>2</sup> Leen Kim<sup>2</sup> </p>
<p><sup>1</sup>Department of Psychiatry, Gil Medical Center, Gachon University, College of Medicine, Incheon, Republic of Korea</p>
<p><sup>2</sup>Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea</p>
<p> </p>
<p>Part III. Therapeutic intervention for treatment resistance</p>
<p> </p>
<p>Chapter 19. Creative, person-centered psychopharmacology for treatment resistance in psychiatry</p>
<p>Miro Jakovljevic</p>
<p>University Hospital Centre Zagreb, Department of Psychiatry, Zagreb, Croatia</p>
<p> </p>
<p>Chapter 20. A psychodynamic approach to treatment resistance</p>
<p>Elizabeth Weinberg, Erin Seery, Eric M. Plakun, </p>
<p>The Austen Rigges Center, Stockbridge, MA, USA </p>
<p> </p>
<p>Chapter 21. Cognitive behavioral therapy and behavioral activation therapy for treatment resistant depression: traditional and digital therapy perspectives</p>
Jennifer A. Apolinário-Hagen, Lara Fritsche, Liesemarie Albers, Christel Salewski <p></p>
<p>Department of Health Psychology, University of Hagen, Hagen, Germany. </p>
<p> </p>
<p>Chapter 22. Novel neurostimulation therapeutic approaches for treatment resistant psychiatric disorders</p>
<p>Ralph J. Koek, Janine Roach, Nicholas Athanasiou, Arkady Korotinsky</p>
<p>Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the UCLA, Los Angeles, USA</p>
<p> </p>
<p>Chapter 23. When clozapine fails: augmentation strategies in the management of clozapine-resistant schizophrenia</p>
<p> </p>
<p>Domenico De Berardis,<sup>1</sup> Michele Fornaro, Annalisa Anastasia, Federica Vellante , Alessandro Valchera, Marilde Cavuto, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Laura Orsolini, Carmine Tomasetti, Gabriella Di Emidio, Giovanni Martinotti, Massimo Di Giannantonio </p>
<p><sup>1</sup>NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy</p>
<p> </p>
<p>Chapter 24. Fecal microbiota transplantation in the treatment resistant psychiatric disorders</p>
<p>Alper Evrensel, Mehmet Emin Ceylan </p>
<p>Department of Psychiatry, Uskudar University, Istanbul, Turkey</p>
<p> </p>
<p>Chapter 25. Neurosurgical intervention for treatment-resistant psychiatric disorders</p>
<p>Daniel E. Nijensohn,<sup>1</sup> Teodoro Forcht Dagi <sup>2</sup></p>
<p><sup>1</sup> Honorary Professor, Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA </p>
<p><sup>2 </sup>Distinguished Scholar and Professor at the School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, Northern Ireland</p>
<p> </p><p></p>
